Hillenkamp J, Saikia P, Gora F, Sachs H G, Lohmann C P, Roider J, Bäumler W, Gabel V-P
Department of Ophthalmology, University of Regensburg, Eye Hospital, Franz-Josef-Strauss-Allee 11, D-93042 Regensburg, Germany.
Br J Ophthalmol. 2005 Apr;89(4):437-43. doi: 10.1136/bjo.2004.051250.
To investigate macular function and morphology after surgical removal of idiopathic epiretinal membrane (IEM) with and without assistance of indocyanine green (ICG).
A retrospective study as a consecutive case series, of 39 patients with IEM. 39 patients, 23 female, 16 male, mean age 67 years, underwent standard three port pars plana vitrectomy with removal of epiretinal membrane. Two groups of patients were consecutively operated: in 20 patients ICG 0.1% in glucose 5% was used to stain the epiretinal membrane. 19 patients underwent the identical procedure but without use of ICG. Postoperative follow up was 1-92 months (mean 15.5 months). Functional outcome was assessed with subjective improvement, best corrected visual acuity (BCVA), Amsler grid test, 10 degrees and 30 degrees automated perimetry (Heidelberg visual field analyser) (HFA), and Goldmann kinetic perimetry. Macular morphology was assessed with stereoscopic biomicroscopy and optical coherence tomography (OCT). The main outcome measures were macular function as determined by BCVA, presence of visual field defects, and metamorphopsia as determined by Amsler grid test, macular morphology as determined by slit lamp biomicroscopy, and OCT.
BCVA improved in 28 patients, remained unchanged in eight patients, and decreased in three patients. Improvement of BCVA was statistically significant in both groups (p = 0.003). Mean BCVA in patients operated with ICG improved from 0.33 preoperatively to 0.53 postoperatively. Mean BCVA in patients operated without ICG improved from 0.32 preoperatively to 0.54 postoperatively. Reduction of macular oedema as measured by OCT was statistically significant in both groups (p<0.01). There was no statistically significant difference in postoperative BCVA, macular oedema as measured by OCT, postoperative Amsler grid test, and subjective improvement between the two groups. The incidence of residual or recurrent epiretinal membrane was greater in the group operated without ICG (p = 0.014). Visual field defects were detected in one patient operated with ICG and in three patients operated without ICG.
Removal of epiretinal tissue with or without assistance of ICG improved visual function and reduced macular oedema in most patients. Adverse effects clearly attributable to the use of ICG were not observed but further investigation is warranted.
研究在有或没有吲哚菁绿(ICG)辅助的情况下,手术切除特发性视网膜前膜(IEM)后黄斑的功能和形态。
一项回顾性研究,作为连续病例系列,纳入39例IEM患者。39例患者中,女性23例,男性16例,平均年龄67岁,接受了标准的三通道玻璃体切除术并切除视网膜前膜。两组患者连续接受手术:20例患者使用5%葡萄糖溶液中的0.1% ICG对视网膜前膜进行染色。19例患者接受相同手术,但未使用ICG。术后随访1 - 92个月(平均15.5个月)。通过主观改善情况、最佳矫正视力(BCVA)、Amsler方格表测试、10度和30度自动视野检查(海德堡视野分析仪)(HFA)以及Goldmann动态视野检查评估功能结果。通过立体显微镜检查和光学相干断层扫描(OCT)评估黄斑形态。主要观察指标为由BCVA确定的黄斑功能、视野缺损的存在情况以及由Amsler方格表测试确定的视物变形,由裂隙灯显微镜检查和OCT确定的黄斑形态。
28例患者的BCVA提高,8例患者保持不变,3例患者下降。两组患者BCVA的改善均具有统计学意义(p = 0.003)。使用ICG手术的患者术前平均BCVA为0.33,术后为0.53。未使用ICG手术的患者术前平均BCVA为0.32,术后为0.54。两组患者经OCT测量的黄斑水肿减轻均具有统计学意义(p<0.01)。两组患者术后BCVA、经OCT测量的黄斑水肿、术后Amsler方格表测试以及主观改善情况均无统计学显著差异。未使用ICG手术的组中视网膜前膜残留或复发的发生率更高(p = 0.014)。在使用ICG手术的1例患者和未使用ICG手术的3例患者中检测到视野缺损。
在有或没有ICG辅助的情况下切除视网膜前组织,可改善大多数患者的视觉功能并减轻黄斑水肿。未观察到明显归因于使用ICG的不良反应,但仍需进一步研究。